Navigation Links
Corgenix to Host Conference Call to Discuss First Quarter Results
Date:11/6/2008

DENVER, Nov. 6 /PRNewswire-FirstCall/ -- Corgenix Medical Corporation (OTC Bulletin Board: CONX), a worldwide developer and marketer of diagnostic test kits, will host a conference call on Thursday, November 13, 2008, at 4:00 PM EST to discuss the Company's financial and operating performance for its first fiscal quarter ended September 30, 2008, and the status of the Company's product development and marketing activities.

Corgenix invites all those interested in hearing management's discussion of the annual results to join the call by dialing:

U.S. attendees: (800) 895-0198

International attendees: +1 785 424 1053

Conference code is: CORGENIX

A question-and-answer session will follow the presentation by Corgenix management.

A replay will be available for 30 days following the call by dialing (800) 723-0544 for U.S. participants and +1 402 220 2656 for international participants.

About Corgenix Medical Corporation

Corgenix is a leader in the development and manufacturing of specialized diagnostic kits for immunology disorders, vascular diseases and bone and joint disorders, including the world's only non-blood-based test for aspirin effect. Corgenix diagnostic products are commercialized for use in clinical laboratories throughout the world. The company currently sells over 52 diagnostic products through a global distribution network. More information is available at http://www.corgenix.com.


'/>"/>
SOURCE Corgenix Medical Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Corgenix to Exhibit AspirinWorks(R) Test, Discuss New CHARISMA Trial Results at AHA 2008 Meeting
2. Corgenix Receives Third U.S. Patent on AtherOx(R) Technology
3. Corgenix Reports Fiscal 2008 Financial Results
4. Corgenix to Host Conference Call to Discuss Fiscal 2008 Results
5. Corgenix Expands Scientific Advisory Board
6. Corgenix to Exhibit AspirinWorks(R) Test at ADA 2008 Meeting in San Francisco
7. Corgenix to Host Conference Call to Discuss Third Quarter Fiscal 2008 Results
8. Corgenix Announces FDA Clearance for IgG Anti-AtherOx(R) Test Kit
9. Corgenix to Exhibit AspirinWorks(R) Test at ACC 2008 Meeting in Chicago
10. Corgenix Signs Technology Licensing Agreement With Japanese Government
11. Access Pharmaceuticals to Present at the Rodman & Renshaw Annual Global Investment Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/11/2017)... , ... August 11, 2017 , ... Algenist continues to ... formulation unlocking collagen like never before. , Collagen is the key structural element ... market with Liquid Collagen™, which include: , First to ...
(Date:8/10/2017)... ... August 09, 2017 , ... Teachers from three Philadelphia ... August 14th through the 16th, the University City Science Center will kick off ... 2016, provides Philadelphia-based middle school educators an opportunity for professional development related to ...
(Date:8/10/2017)... Bahama (PRWEB) , ... August 09, 2017 , ... Okyanos ... will take place at the Pelican Bay Hotel in Freeport, Grand Bahama on September ... pre-registration is required. , With oversight from the Ministry of Health’s National Stem ...
(Date:8/10/2017)... ... August 10, 2017 , ... ... establishing Kinokuniya Company Ltd. as its exclusive sales representative for SPIE Journals in ... for the SPIE Digital Library in Japan. , “We look forward to expanding ...
Breaking Biology Technology:
(Date:4/3/2017)... , April 3, 2017  Data captured ... engineering platform, detected a statistically significant association ... prior to treatment and objective response of ... potential to predict whether cancer patients will ... treatment, as well as to improve both pre-infusion ...
(Date:3/30/2017)... KONG , March 30, 2017 The ... a system for three-dimensional (3D) fingerprint identification by adopting ground breaking ... into a new realm of speed and accuracy for use in ... at an affordable cost. ... ...
(Date:3/29/2017)...  higi, the health IT company that operates the ... , today announced a Series B investment from ... The new investment and acquisition accelerates higi,s strategy to ... population health activities through the collection and workflow integration ... collects and secures data today on behalf of over ...
Breaking Biology News(10 mins):